| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $96K | — | +0.0% |
| Cost of Revenue | $285 | — | +0.0% |
| Gross Profit | $96K | — | +0.0% |
| R&D Expense | $12K | — | +0.0% |
| SG&A Expense | $3.9M | +17.3% | +5.4% |
| Operating Income | -$3.9M | -17.3% | -8.2% |
| Pre-tax Income | -$3.9M | +21.8% | -6.0% |
| Income Tax | $2K | +0.0% | — |
| Net Income | -$3.9M | +21.8% | -6.0% |
| EPS (Basic) | -$0.20 | +23.1% | +0.0% |
| EPS (Diluted) | -$0.20 | +23.1% | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $107 | +0.0% | -100.0% |
| Inventory | $1.0M | -0.1% | +429.8% |
| Current Assets | $6.7M | +2.9% | +10.5% |
| Total Assets | $71.5M | -0.6% | -11.6% |
| Current Liabilities | $73.5M | +4.3% | +19.2% |
| Long-term Debt | $200K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | $7K | — | — |
| Financing Cash Flow | $3.7M | — | — |
| Free Cash Flow | -$4.2M | — | — |
| — |
| Total Liabilities | $73.8M | +4.7% | +19.1% |
| Stockholders' Equity | -$2.3M | -252.9% | -112.0% |